TABLE 3.
Recent formulations of antibiotic combinations with natural compounds towards bacterial pathogen.
| Antibiotic | Combination | Target to organism | References |
| Ciprofloxacin | Chitosan | Escherichia coli | Erman et al., 2017 |
| Penicillin | Nisin I4V | S. pseudintermedius DSM 21284 | Field et al., 2016 |
| Chloramphenicol | Nisin, nisin V, and nisin I4V derivatives | S. aureus SA113 | Field et al., 2016 |
| Vancomycin | Propolis extract | MRSA 10442 | Al-Ani et al., 2018 |
| Oxacillin | Propolis extract | MRSA 10443 | Al-Ani et al., 2018 |
| Vancomycin | Propolis extract | E. faecalis 51299 | Al-Ani et al., 2018 |
| Levofloxacin | Propolis extract | S. pneumoniae 49619 | Al-Ani et al., 2018 |
| Levofloxacin | Propolis extract | H. influenza 49747 | Al-Ani et al., 2018 |
| Vancomycin | Propolis extract | S. pyogenes12344 | Al-Ani et al., 2018 |
| Ofloxacin | Calixarene 2 | S. epidermidis ATCC 35984, P. aeruginosa isolate | Consoli et al., 2018 |
| Chloramphenicol | Calixarene 2 | MRSA 15 | Consoli et al., 2018 |
| Chloramphenicol | Calixarene 2 | P. aeruginosa ATCC 9027 | Consoli et al., 2018 |
| Cefuroxime | Rosehip, pomegranate blossom, rosehip bag | E. coli | Hacioglu et al., 2017 |
| Ampicillin-Sulbactam | Pomegranate blossom, rosehip bag, rosehip | E. coli | Hacioglu et al., 2017 |
| Ciprofloxacin | Pomegranate blossom, rosehip, rosehip bag | E. coli | Hacioglu et al., 2017 |
| Ciprofloxacin / Ceftazidime/Amikacin | Rosehip, pomegranate blossom, green tea, rosehip bag, black tea bag, black tea | P. aeruginosa | Hacioglu et al., 2017 |
| Erythromycin/Ciprofloxacin/Ampicillin | Rosehip, pomegranate blossom, black tea, green tea, rosehip bag, green tea bag, Thyme, wormwood, mint, sage bag, mint bag, echinacea bag, black tea bag, orengo | MSSA | Hacioglu et al., 2017 |
| Vancomycin/Gentamicin/Ciprofloxacin/Linezolid/Daptomycin, | P128 (antistaphylococcal protein) | Staphylococcus aureus | Nair et al., 2016 |
| Imipenem | Colistin | E. coli, K. pneumoniae | Dosler et al., 2016 |
| Cefotaxime/Amikacin | Bile acid oligomers | Staphylococcus aureus | Singla et al., 2018 |
| Ampicillin/Meropenem/Cefazolin/Cefotaxime/Cefpirome/Cefuroxime | Pongamia pinnata seed coat extract | Methicillin-resistant Staphylococcus aureus | Su et al., 2020 |
| Cefoxitin/Mupirocin/Co-Trimoxazole/Ciprofloxacin | Fennel essential oil | Staphylococcus aureus | Kwiatkowski et al., 2017 |
| Oxacillin, Ceftazidime/Fluconazole. | Alpinia purpurata | S. aureus and C. albicans | Ferreira et al., 2018 |
| Penicillin, Ampicillin/Erythromycin | Trp-containing antimicrobial peptides (amps) | Staphylococcus epidermidis | Shang et al., 2019 |
| Clarithromycin/Metronidazole | Hibiscus sabdariffa | Helicobacter pylori | Hassan et al., 2016 |